Tissue studies indicated that PDE8B expression decreases significantly in higher-grade GBM tissues compared to adjacent normal tissues, paralleling the progression to an immunosuppressed tumor microenvironment where both immune cells and PDE8B expression are diminished. The gene discussed is PDE8B; the disease is glioblastoma.